In a recent concise video, Marc Ellazidi, Fund Manager of Merill Funds, highlights Denmark's rise as a global leader in pharmaceuticals, driven by major companies like Novo Nordisk, which spearhead innovation and research. The country's robust biotech ecosystem supports significant advancements in medical science and chronic disease treatment.
Watch the video on our LinkedIn page through the link below: